ZA200908262B - Macrocycles and their uses - Google Patents

Macrocycles and their uses

Info

Publication number
ZA200908262B
ZA200908262B ZA200908262A ZA200908262A ZA200908262B ZA 200908262 B ZA200908262 B ZA 200908262B ZA 200908262 A ZA200908262 A ZA 200908262A ZA 200908262 A ZA200908262 A ZA 200908262A ZA 200908262 B ZA200908262 B ZA 200908262B
Authority
ZA
South Africa
Prior art keywords
macrocycles
Prior art date
Application number
ZA200908262A
Other languages
English (en)
Inventor
Roger Aki Fujimoto
Philipp Krastel
Matthew J Lamarche
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA200908262B publication Critical patent/ZA200908262B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200908262A 2007-06-04 2009-11-23 Macrocycles and their uses ZA200908262B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94177707P 2007-06-04 2007-06-04

Publications (1)

Publication Number Publication Date
ZA200908262B true ZA200908262B (en) 2010-08-25

Family

ID=40094226

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200908262A ZA200908262B (en) 2007-06-04 2009-11-23 Macrocycles and their uses

Country Status (24)

Country Link
US (2) US8476224B2 (xx)
EP (1) EP2170907A2 (xx)
JP (1) JP2010529076A (xx)
KR (1) KR101202483B1 (xx)
CN (1) CN101772506B (xx)
AR (1) AR066865A1 (xx)
AU (1) AU2008258639B2 (xx)
BR (1) BRPI0812340A2 (xx)
CA (1) CA2688621A1 (xx)
CL (1) CL2008001613A1 (xx)
CO (1) CO6270222A2 (xx)
CR (1) CR11158A (xx)
EA (1) EA200901613A1 (xx)
EC (1) ECSP099836A (xx)
GT (1) GT200900310A (xx)
IL (1) IL202285A0 (xx)
MA (1) MA31562B1 (xx)
MX (1) MX2009013214A (xx)
NZ (1) NZ581917A (xx)
PE (1) PE20090318A1 (xx)
TN (1) TN2009000495A1 (xx)
TW (1) TW200902540A (xx)
WO (1) WO2008148754A2 (xx)
ZA (1) ZA200908262B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008334659A1 (en) 2007-12-12 2009-06-18 Novartis Ag Aminothiazoles and their uses
US10933019B2 (en) * 2016-10-21 2021-03-02 Xellia Pharmaceuticals Aps Liquid formulations of daptomycin
CN109485617B (zh) * 2018-12-11 2023-01-31 贵州永诺菲特生物制药有限公司 一种n-甲基-2-异丙基-4-噻唑甲胺的制备方法
WO2024044751A2 (en) * 2022-08-26 2024-02-29 Wake Forest University Health Sciences Peroxiredoxin 3 inhibitors and methods of use for treating cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0451486T3 (da) 1990-03-08 1995-05-08 Lepetit Spa Antibiotikum GE 2270 faktorer B1, B2, C1, C2, D1, D2, E og T
DE4011378A1 (de) 1990-04-07 1991-10-10 Hausen Auto Kabel Gmbh & Co Kg Anschlussklemme fuer akkumulator oder dergleichen
IL100572A (en) * 1991-01-03 1997-01-10 Lepetit Spa Amides of antibiotic ge 2270 factors their preparation and pharmaceutical compositions containing them
ATE163428T1 (de) 1991-08-30 1998-03-15 Biosearch Italia Spa Faktor c2a des antibiotikums ce 2270
ATE231163T1 (de) 1996-02-14 2003-02-15 Biosearch Italia Spa Derivate des antibiotisch wirkenden faktors ge2270
JPH1059997A (ja) 1996-08-22 1998-03-03 Microbial Chem Res Found アミチアマイシンアミド誘導体
JP4723857B2 (ja) * 2002-06-17 2011-07-13 ヴィキュロン ファーマシューティカルズ インコーポレイテッド アクネの治療のためのｇｅ２２７０因子ａ３のアミド誘導体の使用
US20050106159A1 (en) * 2003-08-12 2005-05-19 Thompson Stuart A. Campylobacter jejuni outer membrane protein immunogenic composition
AR060977A1 (es) 2006-05-31 2008-07-23 Novartis Ag Aminotiazoles y sus usos
AU2007339279A1 (en) * 2006-12-20 2008-07-10 Novartis Ag Aminothiazole macrocycles, their use as antibacterial compounds and processes for their production

Also Published As

Publication number Publication date
PE20090318A1 (es) 2009-04-17
AU2008258639A1 (en) 2008-12-11
US20130252883A1 (en) 2013-09-26
ECSP099836A (es) 2010-01-29
US8476224B2 (en) 2013-07-02
KR101202483B1 (ko) 2012-11-16
KR20100021496A (ko) 2010-02-24
JP2010529076A (ja) 2010-08-26
NZ581917A (en) 2011-04-29
IL202285A0 (en) 2010-06-16
CR11158A (es) 2010-01-20
US20090186830A1 (en) 2009-07-23
CO6270222A2 (es) 2011-04-20
EA200901613A1 (ru) 2010-06-30
CN101772506A (zh) 2010-07-07
WO2008148754A2 (en) 2008-12-11
WO2008148754A3 (en) 2009-03-05
US8691756B2 (en) 2014-04-08
CL2008001613A1 (es) 2009-05-15
CN101772506B (zh) 2014-02-12
CA2688621A1 (en) 2008-12-11
AU2008258639B2 (en) 2012-07-05
MX2009013214A (es) 2010-01-15
TN2009000495A1 (en) 2011-03-31
TW200902540A (en) 2009-01-16
AR066865A1 (es) 2009-09-16
MA31562B1 (fr) 2010-08-02
EP2170907A2 (en) 2010-04-07
BRPI0812340A2 (pt) 2015-01-27
GT200900310A (es) 2010-05-21

Similar Documents

Publication Publication Date Title
IL205571A0 (en) 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin
TWI561237B (en) Substituted dihydropyrazolones and their use
GB0701426D0 (en) Compounds and their use
EP2185692A4 (en) HCO32 AND HCO27 AND RELATED EXAMPLES
EP2114900A4 (en) COMPOUNDS ON THIOPYRIMIDINE BASE AND APPLICATIONS THEREOF
PL2034088T3 (pl) Tkanina i laminat tkaniny
IL210804A (en) Benzylidenehydrazides and their uses
ZA200810323B (en) Fkbp-l and uses thereof
EP2123644A4 (en) BENZOXAZEPINE DERIVATIVES AND THEIR USE
LT2064327T (lt) Dbait ir jų panaudojimas
PL2222314T3 (pl) Zastosowanie i sposoby uzyskania rozluźnienia oskrzeli
GB2452568B (en) Fabric and fabric laminate
HK1133552A1 (en) Carboranylporphyrins and uses thereof
ZA201103456B (en) Leukolectins and uses thereof
EP2291377A4 (en) IMIDAZOPYRIMIDINONE AND ITS USES
EP2247601A4 (en) THIAZOPYRIMIDINONE AND APPLICATIONS THEREOF
IL202285A0 (en) Macrocycles and their uses
ZA201000357B (en) 2-Azetidinemethaneamines and 2-pyrrolidinemethaneamines as Taar-Ligands
IL206104A0 (en) Aminothiazoles and their uses
ZA201100182B (en) New terpenes and macrocycles
HK1146065A1 (en) Nlrr-1 antagonists and uses thereof nlrr-1
GB0707069D0 (en) Methods and uses
GB0708445D0 (en) Compounds and uses thereof
GB0707609D0 (en) Methods and uses
GB0722451D0 (en) Methods and uses